Creative Biolabs provides pro-inflammatory cytokine and chemokine signature profiling, utilizing multiplex immunoassays to quantify Th1/Th17-driven inflammation. We evaluate secretome shifts and chemokine gradients to identify high-potency immunotherapeutic leads.
Learn More →Chronic Inflammation & Tumor-Promoting Inflammatory Signaling Analysis Services
Creative Biolabs offers a modular analytical framework designed to dissect the seventh hallmark of cancer, quantifying the transition from acute immune responses to chronic, pro-tumorigenic signaling. Our platform identifies molecular drivers by providing high-resolution data on how inflammatory mediators trigger genomic instability, enabling the discovery of high-value targets within the tumor niche. We further provide therapeutic candidate validation by measuring the inhibition of key transcription factors like STAT3. By delivering a precise mechanistic fingerprint of your drug candidate, we ensure your development pipeline is robustly grounded in evidence-based molecular pivots.
Background Featured Services Workflow Publication Why Choose Us FAQs Customer Review Related Services Contact Us
Introduction to Tumor-Promoting Inflammatory Signaling
Chronic inflammation acts as the fuel for neoplastic transformation, creating a microenvironment rich in cytokines, growth factors, and reactive species. By activating self-reinforcing loops, such as the IL-6/STAT3 axis, the tumor microenvironment hijacks homeostatic repair mechanisms to drive cell survival, angiogenesis, and metastasis. Current scientific consensus emphasizes that targeting these tumor-supportive inflammatory signals is critical for overcoming resistance to immunotherapies. Creative Biolabs offers the specialized infrastructure to deconstruct these networks and identify high-value therapeutic targets. Our analysis focuses on how persistent inflammatory stress induces DNA damage and promotes the expansion of cancer stem-like cells.
Comprehensive Multi-Dimensional Analysis Solutions
Pro-inflammatory Cytokine & Chemokine Signature Profiling
NF-κB/STAT3 Chronic Inflammatory Pathway Activation Mapping
Creative Biolabs maps NF-κB and STAT3 chronic activation, integrating p-p65 and p-STAT3 co-localization. We quantify pro-inflammatory feedback loops to evaluate genomic instability and identify high-value therapeutic targets.
Learn More →Inflammation driven Tumor Microenvironment Remodeling Analysis
Creative Biolabs provides inflammation-driven tumor microenvironment (TME) remodeling analysis, quantifying the transition from acute immunity to chronic pro-tumorigenic signaling. We evaluate genomic instability and STAT3-mediated molecular pivots to identify high-value therapeutic targets.
Learn More →Immune-Inflammatory Crosstalk & Carcinogenesis Assessment
Creative Biolabs assesses immune-inflammatory crosstalk and carcinogenesis, quantifying the transition from acute inflammation to pro-tumorigenic signaling. We evaluate genomic instability and STAT3 inhibition to identify high-value therapeutic targets.
Learn More →Environmental/Exposure induced Inflammatory Response Characterization
Creative Biolabs delivers environmental-induced inflammatory response characterization, utilizing multi-parametric phenotyping and redox signaling assays. We quantify oxidative stress and cytokine kinetics to evaluate toxicant-driven inflammation and identify protective leads.
Learn More →Is your research hitting a bottleneck in TME characterization? — Request a Strategy Session with Our Oncology Specialists
Workflow
Our analytical workflow is a meticulously structured process designed to bridge the gap between raw biological samples and actionable therapeutic insights.
Publication
This review comprehensively examines the multifaceted role of inflammation in cancer, highlighting its involvement in tumor initiation, progression, and metastasis. It explains how chronic inflammation promotes genetic instability, epigenetic alterations, and a tumor-supportive microenvironment, while also facilitating angiogenesis, immune evasion, and metastatic spread. Importantly, the study emphasizes the dual nature of inflammation, noting its potential to both enhance tumor growth and stimulate antitumor immunity, thereby presenting promising opportunities for targeted therapeutic interventions in cancer treatment.
Fig.1 Chronic inflammation in tumor initiation: driving mutations, genomic instability, and epigenetic changes. 1
Why Choose Us?
Creative Biolabs integrates technical excellence with a deep understanding of inflammatory biology. Our platform utilizes advanced spatial transcriptomics and single-cell analysis to distinguish between hijacked homeostatic cells and true pro-inflammatory effectors. Based on published data, we have demonstrated that remodeling the TME to inhibit the IL-23/IL-17 axis can significantly improve the efficacy of standard oncology treatments. Our ability to provide a 360-degree view of the TME makes us a preferred partner for global biopharmaceutical leaders. We offer proprietary high-throughput screening platforms and innovative protein engineering techniques that accelerate the identification of potent inflammatory modulators.
Partner with the leaders in TME analysis — Request a Formal Proposal and Project Timeline
FAQs
How does your signaling analysis differ from standard gene expression profiling?
While gene expression shows potential, our analysis incorporates phospho-protein kinetics and functional assays (e.g., ROS quantification) to reveal the actual activation state of the inflammatory pathways.
Can your platform handle complex co-culture models?
Yes, Creative Biolabs specializes in 3D organoid co-cultures that integrate cancer cells with fibroblasts (CAFs) and various immune subsets to replicate the spatial architecture of an inflamed tumor.
Are your services compatible with large-scale antibody screening?
Absolutely. We offer high-throughput platforms that can evaluate the impact of multiple antibody candidates on inflammatory cytokine release and downstream signaling simultaneously.
Customer Review
-
Enhanced Clarity in TME Modeling
Using Creative Biolabs' signaling analysis in our research has significantly facilitated our understanding of how MIF-driven pathways contribute to chemoresistance in pancreatic models. - Dr. A***n L -
Robust Cytokine Profiling
The multiplex assays provided by Creative Biolabs were instrumental in mapping the IL-1β secretome of our patient-derived samples. Their precision in detecting low-abundance chemokines is unmatched. - Prof. S***a K
Related Services
To further your research into the inflammatory niche, we recommend:
Ferroptosis-mediated Crosstalk within the Tumor Microenvironment (TME)
Creative Biolabs provides ferroptosis-mediated crosstalk analysis, utilizing scRNA-seq and immunophenotypic profiling. We quantify TME remodeling, ECM transition, and immune escape to evaluate ferroptosis-targeted immunotherapy leads and intercellular signaling networks.
Learn More →Immune Checkpoint Blocking (ICB) Therapy Development
Creative Biolabs provides ICB-based therapy development, specializing in target validation and drug screening to overcome cancer resistance. We evaluate immune checkpoint kinetics and antitumor activity to quantify treatment efficacy and identify high-potency leads for preclinical translation.
Learn More →How to Contact Creative Biolabs
Creative Biolabs offers an industry-leading suite of analysis services designed to deconstruct the complex relationship between chronic inflammation and cancer. From molecular signaling dissection to 3D functional validation, we provide the data-driven insights necessary to accelerate your drug discovery programs.
Contact Creative Biolabs today to consult with a specialist and design your customized inflammatory signaling analysis program.
Reference
- Nishida, Atsushi, and Akira Andoh. "The role of inflammation in cancer: mechanisms of tumor initiation, progression, and metastasis." Cells 14.7 (2025): 488. Distributed under Open Access license CC BY 4.0, without modification. https://doi.org/10.3390/cells14070488
Download our brochureLoading case studies...
Online Inquiry